Lintuzumab Antibody
Lintuzumab (HuM-195) is a humanized monoclonal antibody targeting CD33 on AML cells. It exhibits anti-leukemic activity by inducing cell death via CDC/ADCC and modulating cytokine production. This agent has been investigated in both in vitro assays and clinical trials for acute myeloid leukemia research.
Product Specifications
Product Name Alternative
SGN33, SGN-33, CD33, HuM195, HuM-195, Immunologyrelated, Immunology related, Inflammationrelated, Inflammation related
Target
Immunology/Inflammation related, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.43 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.23 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ELAC2 (HPC2, Zinc Phosphodiesterase ELAC Protein 2, ElaC Homolog Protein 2, Heredity Prostate Cancer Protein 2, Ribonuclease Z 2, tRNA 3 Endonuclease 2, tRNase Z 2, FLJ10530, FLJ36693, FLJ42848) (Biotin)
ELAC2 (HPC2, Zinc Phosphodiesterase ELAC Protein 2, ElaC Homolog Protein 2, Heredity Prostate Cancer Protein 2, Ribonuclease Z 2, tRNA 3 Endonuclease 2, tRNase Z 2, FLJ10530, FLJ36693, FLJ42848) (Biotin)